Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.550
-0.070 (-4.32%)
At close: May 12, 2025, 4:00 PM
1.540
-0.010 (-0.65%)
After-hours: May 12, 2025, 4:01 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.51 million as of May 12, 2025. Its market cap has decreased by -69.68% in one year.
Market Cap
8.51M
Enterprise Value
-14.34M
1-Year Change
-69.68%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.51M, a decrease of -55.04%. That is a compound annual growth rate of -23.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 8.90M | -50.24% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |